Top Markets
Coin of the day
Original BioMedicals Co., Ltd. Original BioMedicals Co., Ltd.

Original BioMedicals Co., Ltd.

6483
Classifica tra le azioni #27912
Original BioMedicals Co., Ltd. is a biotechnology company focused on creating... Original BioMedicals Co., Ltd. is a biotechnology company focused on creating novel chemical compounds to fulfill critical medical requirements, with an initial emphasis on the healthcare landscape in Taiwan. Its current product pipeline encompasses several key developments: Radprotect (A01): A pre-clinical stage compound designed to offer protection against radiation exposure. CCM-Ami (A02): Engineered to shield healthy tissues from the damaging side effects of both chemotherapy drugs and ionizing radiation. GLP-1 CCM (P01): A therapeutic agent developed for the management of type 2 diabetes. The firm was established in 2011 and operates from its base in Taipei, Taiwan.
Prezzo delle azioni
$0.44677634
Capitalizzazione di mercato
$29.85M
Variazione (1 giorno)
0.36%
Variazione (1 anno)
-2.97%
Paese
TW
Scambia Original BioMedicals Co., Ltd. (6483)

Categoria

Rapporto P/B per Original BioMedicals Co., Ltd. (6483)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Original BioMedicals Co., Ltd., il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per Original BioMedicals Co., Ltd. da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti